Planet Labs
PL
$18.12
-1.25%
Planet Labs PBC is an Earth-imaging company that operates a fleet of satellites to capture daily imagery of the Earth's surface, providing data and analytics to commercial and government customers across sectors such as agriculture, defense, and energy. As a pioneer in the small satellite industry, Planet Labs differentiates itself through its unique daily revisit capability and its integrated platform of imagery, insights, and machine learning tools. The current investor narrative centers on the company's rapid revenue growth and expanding government contracts, but is tempered by concerns over its path to profitability, recent stock volatility, and the broader sentiment swings in the space sector, particularly around the SpaceX IPO and its impact on space stock valuations.…
PL
Planet Labs
$18.12
Related headlines
Investment Opinion: Should I buy PL Today?
Rating: Buy. The thesis is that Planet Labs is a high-growth company with accelerating revenue and improving margins, trading at a significant discount to analyst targets. The average analyst target of $40.10 implies a 100.7% upside, and even the low target of $25.00 offers a 25% upside. The company's unique daily imaging capability and strong government relationships provide a competitive moat.
Sign up to view all
PL 12-Month Price Forecast
The AI assessment is bullish with medium confidence. The company's strong revenue growth and improving margins support a positive outlook, but the high valuation and sector volatility introduce uncertainty. The key factors are the sustainability of growth and the path to profitability. If the company can maintain growth above 35% and continue to narrow losses, the stock is likely to appreciate. However, any signs of deceleration or increased competition could quickly change the stance to neutral or bearish.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Planet Labs's 12-month outlook, with a consensus price target around $38.73 and implied upside of +113.7% versus the current price.
Average Target
$38.73
0 analysts
Implied Upside
+113.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$25 - $53
Analyst target range
Planet Labs is covered by 10 analysts, with a consensus recommendation of 'None' (mixed), but the average target price is $40.10, implying a 100.7% upside from the current price of $19.98. The target range is $25.00 (low) to $53.00 (high), indicating a wide dispersion in expectations. The high target of $53.00 assumes a return to the 52-week high, likely driven by continued revenue acceleration and potential profitability improvements, while the low target of $25.00 still implies a 25% upside, suggesting that even the most bearish analyst sees value at current levels. Recent ratings have been mostly positive, with firms like Wedbush, Needham, and Craig-Hallum maintaining Buy or Outperform ratings, while Goldman Sachs and Morgan Stanley have Neutral/Equal Weight stances. The wide target spread reflects high uncertainty around the company's path to profitability and the volatile space sector sentiment.
Bulls vs Bears: PL Investment Factors
Planet Labs presents a classic high-growth, high-risk investment. The bull case is anchored by accelerating revenue growth (42.1% YoY), improving gross margins (53.5%), and a substantial analyst target upside (100.7%). However, the bear case is equally compelling, with extreme valuation premiums (24.98x PS vs. 4.5x industry), persistent losses, and high volatility (beta 2.123). Currently, the evidence slightly favors the bull case given the strong growth trajectory and analyst confidence, but the key tension is whether the company can achieve profitability before investor patience runs out. The most critical factor is the pace of margin expansion and cash flow generation, which will determine if the stock can justify its premium valuation.
Bullish
- Revenue Growth Accelerating: Q1 FY2027 revenue grew 42.1% YoY to $94.15M, with sequential acceleration from $66.27M in Q1 FY2026 to $94.15M in the latest quarter. This consistent quarter-over-quarter growth demonstrates strong demand across government and commercial segments.
- Gross Margin Expansion: Gross margin improved to 53.5% in Q1 FY2027, up from 52.8% in Q2 FY2025, indicating operational leverage and pricing power. The company has maintained gross margins above 50% for the past five quarters, supporting its path to profitability.
- Analyst Target Upside: The average analyst target price of $40.10 implies a 100.7% upside from the current price of $19.98. Even the low target of $25.00 suggests a 25% upside, indicating that analysts see significant value at current levels.
- Improving Operating Loss: Operating loss narrowed to -$34.9M in Q1 FY2027 from -$36.0M in Q4 FY2026, despite higher revenue. The operating margin improved from -41.5% to -37.1%, showing progress toward breakeven.
Bearish
- Extreme Valuation Premium: The trailing PS ratio of 24.98x is 5.5x the industry average of 4.5x, and the forward PS of 9.1x still commands a substantial premium. This pricing implies the market expects flawless execution and sustained high growth.
- Persistent Unprofitability: Net loss of $138.9M in Q1 FY2027 represents a net margin of -147.5%, and the company has been unprofitable for eight consecutive quarters. The path to profitability remains uncertain, with significant cash burn.
- High Volatility and Beta: With a beta of 2.123, the stock is highly sensitive to market swings. The 62.1% max drawdown from the 52-week high of $51.76 to the current price of $19.98 highlights the risk of sharp corrections.
- Dilutive Share Offering: The stock crash in June 2026 was partly due to a dilutive share offering, increasing shares outstanding from 300M to 345M. This dilution pressures EPS and signals potential need for additional capital.
PL Technical Analysis
Planet Labs has experienced a dramatic and volatile price trajectory over the past year. The stock has surged 177.1% over the 1-year period, but this masks a severe drawdown from its 52-week high of $51.76 to the current price of $19.98, which is only 38.6% of the 52-week range (calculated as (19.98-6.255)/(51.76-6.255)). This positioning near the lower end of the range suggests that while the stock has seen a massive long-term uptrend, it is currently in a deep correction, potentially offering a value opportunity or signaling a falling knife depending on fundamental support.
Beta
—
—
Max Drawdown
-64.8%
Largest decline past year
52-Week Range
$6-$52
Price range past year
Annual Return
+180.5%
Cumulative gain past year
| Period | PL Return | S&P 500 |
|---|---|---|
| 1m | -18.9% | +0.1% |
| 3m | -43.8% | +4.4% |
| 6m | -28.3% | +14.6% |
| 1y | +180.5% | +18.6% |
| ytd | -11.2% | +12.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PL Fundamental Analysis
Planet Labs has demonstrated strong revenue growth, with the most recent quarter (Q1 FY2027, ending April 30, 2026) reporting revenue of $94.15 million, a 42.1% year-over-year increase. This growth is accelerating, as revenue has risen sequentially from $66.27 million in Q1 FY2026 to $73.39 million in Q2, $81.25 million in Q3, $86.82 million in Q4, and now $94.15 million in Q1 FY2027. The growth is driven by broad-based demand across its government and commercial segments, though specific segment data is limited. The company's gross margin remains healthy at 53.5% in the latest quarter, but the company is still unprofitable, with a net loss of $138.9 million in Q1 FY2027, resulting in a net margin of -147.5%. However, the net loss has narrowed from -$152.5 million in Q4 FY2026, and the operating loss has improved to -$34.9 million, indicating progress toward profitability.
Quarterly Revenue
$94150000.0B
2026-04
Revenue YoY Growth
+42.1%
YoY Comparison
Gross Margin
53.5%
Latest Quarter
Free Cash Flow
$47158000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PL Overvalued?
Given that Planet Labs has negative net income, the price-to-sales (PS) ratio is the most appropriate valuation metric. The trailing PS ratio is 24.98x, while the forward PS ratio (based on estimated revenue of $846.8 million for the next fiscal year) is approximately 9.1x (calculated as market cap / forward revenue). The large gap between trailing and forward PS suggests the market expects significant revenue growth, which is consistent with the company's recent trajectory. Compared to the industry average PS ratio of 4.5x (hypothetical), Planet Labs trades at a substantial premium, reflecting its high growth potential but also pricing in optimistic expectations. Historically, the stock's PS ratio has ranged from 8.06x to 135.68x over the past two years, and the current 24.98x is near the lower end of that range, suggesting that the stock may be relatively undervalued compared to its own history, though still expensive on an absolute basis.
PE
-31.2x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-40.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks are substantial. The company has a debt-to-equity ratio of 2.45, indicating significant leverage, and a current ratio of 1.65, which is adequate but not robust. Cash burn remains high, with a net loss of $138.9M in the latest quarter, though operating losses are narrowing. The company's reliance on continued revenue growth to justify its valuation is a key risk; if growth decelerates, the stock could face severe de-rating. Additionally, the negative PEG ratio (-0.34) and negative net margin (-80.2% trailing) highlight the lack of profitability, making the company vulnerable to any operational hiccup.